ASAN FOUNDATION
- Country
- π°π·South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Genetic Analysis for Predicting of Relapse During Steroid Treatment for Autoimmune Pancreatitis (AIP)
- Conditions
- First Posted Date
- 2007-03-07
- Last Posted Date
- 2007-06-26
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT00444444
- Locations
- π°π·
Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of
Study of XELOX With Cetuximab in Advanced Gastric Cancer
- First Posted Date
- 2006-11-10
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 44
- Registration Number
- NCT00398398
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
π°π·Seoul Samsung Medical Center, Seoul, Korea, Republic of
π°π·Korea Cancer Center Hospital, Seoul, Korea, Republic of
Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy
- Conditions
- First Posted Date
- 2006-10-04
- Last Posted Date
- 2006-10-04
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT00383812
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL
- Conditions
- Interventions
- First Posted Date
- 2006-09-22
- Last Posted Date
- 2013-03-15
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 49
- Registration Number
- NCT00379574
- Locations
- π°π·
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
π°π·Asan Medical Cener, Seoul, Korea, Republic of
Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer
- First Posted Date
- 2006-09-19
- Last Posted Date
- 2013-01-23
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 49
- Registration Number
- NCT00378066
- Locations
- π°π·
Yonsei University Hospital, Seoul, Korea, Republic of
π°π·Asan Medical Center, Seoul, Korea, Republic of
π°π·Seoul National University Hospital, Seoul, Korea, Republic of
Gemcitabine for Marginal Zone Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2006-06-15
- Last Posted Date
- 2016-02-17
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 43
- Registration Number
- NCT00337259
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL)
- First Posted Date
- 2006-06-14
- Last Posted Date
- 2018-06-26
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 27
- Registration Number
- NCT00336583
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Zevalin Plus BuCyE High-dose Therapy in B-cell Non-Hodgkin's Lymphoma
- First Posted Date
- 2006-06-14
- Last Posted Date
- 2016-02-17
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 19
- Registration Number
- NCT00336843
- Locations
- π°π·
Asan Medical Center, Departement of Internal Medicine, Division of Oncology, Seoul, Korea, Republic of
Efficacy and Safety of Intravitreal Triamcinolone Acetonide in Eyes With Post Vitrectomy Diabetic Vitreous Hemorrhage
- Conditions
- First Posted Date
- 2006-03-08
- Last Posted Date
- 2007-06-13
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT00300014
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Trial of Adjuvant Chemotherapy for Gastric Cancer
- First Posted Date
- 2006-02-27
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 528
- Registration Number
- NCT00296322
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of